Lineage Cell Therapeutics has found an experienced hearing loss partner to advance a potentially novel transplant for auditory neurons. William Demant Invest, the largest shareholder of Danish hearing ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, ...
Temperature-controlled warehouse REIT Lineage (NASDAQ:LINE) priced its shares at $78 a share, raising more than $4 billion in the year's biggest initial public offering. Lineage sold nearly 57 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results